Plus Therapeutics, Inc. · NASDAQ:PSTV
Highbridge Capital Management LLC reported a 7.10% stake in Plus Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Highbridge Capital Management LLC reported a 7.10% stake in Plus Therapeutics, Inc., 13,157,894 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 7.10%
- Shares
- 13,157,894
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Highbridge Capital Management, LLC | 7.10% | 13,157,894 |
Source
Related
- Plus Therapeutics, Inc.
- Highbridge Capital Management LLC
- Plus Therapeutics, Inc. shareholders
- Form 4 · Andrews Ronald Asbury · Jul 1, 2026
- Form 4 · Sims Andrew John Hugh MacIntyre · Jul 1, 2026
- Form 4 · Hawkins Richard J · Jul 1, 2026
- Form 4 · Guse Kyle · Jul 1, 2026
- Form 4 · van Es-Johansson An · Jul 1, 2026